Why is my fasting insulin low?
Updated October 31, 2026 · 13 sources · Written by the AumniVIDA team
UnitsShort answer
A low fasting insulin with normal glucose usually means your cells are sensitive to insulin, common in lean, active people. Low insulin with high glucose, thirst, frequent urination or weight loss is different: it can signal type 1 diabetes or LADA and needs prompt medical review.

Key takeaways
- 1
Low insulin with normal glucose usually reflects good insulin sensitivity.
- 2
Low insulin with high glucose can mean the pancreas is not making enough insulin [1].
- 3
LADA makes up 2% to 12% of adult-onset diabetes and is often first mistaken for type 2 [2].
- 4
C-peptide, not insulin, is the test used to judge insulin production in diabetes [3].
Is a low fasting insulin good?
Usually, if your fasting glucose is normal. A low insulin then means your cells respond well and the pancreas needs little insulin overnight. Values below the lab's lower limit, such as 2.6 µIU/mL, are worth reading together with glucose.
Because insulin rises to compensate for insulin resistance [4], low fasting insulin with normal glucose generally reflects good sensitivity. In one US clinic, people in the lowest insulin quartile averaged 4.9 µIU/mL and had the lowest odds of prediabetes [5].
Common reasons for a low reading with normal glucose:
- Lean body composition and regular exercise [6].
- A low-carbohydrate or ketogenic diet, which lowers insulin [7] [8].
- A longer fast than usual before the test.
- Lab factors: labs reject hemolyzed samples for insulin [9], and assays differ [10].
Is lower always better? Not necessarily. In lean Japanese adults with a BMI below 22, the lowest HOMA-IR groups had higher mortality than the middle group, a J-shaped curve [11]. This is one cohort and does not prove cause, but it argues against chasing ever-lower numbers.
Can fasting insulin be too low?
Yes, when it comes with high glucose. Then the pancreas may not be making enough insulin, as in type 1 diabetes, LADA or pancreatic disease. The ADA lists frequent urination, excessive thirst and unexplained weight loss as classic symptoms of high blood sugar.
The key is the pairing with glucose. Type 1 diabetes, including latent autoimmune diabetes in adults (LADA), is caused by autoimmune destruction of beta cells and usually leads to absolute insulin deficiency [1]. Diseases of the exocrine pancreas are another cause of diabetes the ADA classifies separately [1].
In these conditions fasting insulin can be low or low-normal while glucose rises. In people who already inject insulin, a fasting insulin test cannot tell you how much insulin your own pancreas makes, because the assay measures injected insulin too and antibodies interfere [9].
When to seek care. See a clinician promptly if a low insulin comes with a fasting glucose of 126 mg/dL (7.0 mmol/L)7.0 mmol/L (126 mg/dL) or more, an HbA1c of 6.5% or more [1], or symptoms such as frequent urination, excessive thirst or unexplained weight loss [1]. Seek urgent care for vomiting, abdominal pain, rapid breathing or confusion with high glucose, which can signal diabetic ketoacidosis.
What are the warning signs of type 1 diabetes or LADA in adults?
LADA looks like type 2 diabetes at first but is autoimmune and progresses toward insulin need. Signs include diabetes in a lean adult, rising glucose despite treatment, weight loss and a personal or family history of autoimmune disease.
An international consensus statement estimates that LADA accounts for 2% to 12% of adult-onset diabetes. At diagnosis people resemble type 2 patients because they do not need insulin, but they carry the immune markers of type 1 diabetes. The panel advised screening for LADA in newly diagnosed diabetes that does not yet need insulin [2].
Clues that diabetes may be autoimmune rather than type 2:
- Diabetes in an adult with a normal or low BMI. The ADA lists a BMI of 25 or more and no weight loss among the features of type 2 diabetes [1].
- Unexplained weight loss, or glucose that keeps rising on standard type 2 treatment.
- A personal or family history of autoimmune conditions, such as thyroid disease (see TSH).
Testing for islet autoantibodies and C-peptide is how clinicians sort this out [1] [2].
Should I test C-peptide instead of fasting insulin?
If the question is how much insulin your pancreas makes in the context of diabetes, yes. C-peptide is released in equal amounts to insulin and is the best measure of the body's own output. Guidelines use it mainly in people on insulin.
C-peptide is cut from proinsulin at the same time as insulin, so it tracks insulin secretion, and injected insulin does not contain it [3].
Thresholds clinicians use:
| C-peptide | What it suggests | Source |
|---|---|---|
| Below 0.2 nmol/L | Type 1 diabetes | [12] |
| Below 0.3 nmol/L (random) | In LADA, a multiple-insulin regimen as for type 1 | [2] |
| 0.3 to 0.7 nmol/L (random) | LADA gray zone | [2] |
| Above 0.6 nmol/L | Type 2 diabetes | [12] |
| 600 pmol/L (0.6 nmol/L) or more, random | Circumstances of testing do not matter | [1] |
| Below 80 pmol/L | Very low; no need to repeat | [1] |
The ADA says a C-peptide test is indicated only in people receiving insulin treatment, and that a random sample with concurrent glucose within 5 hours of eating can replace a formal stimulation test for classification [1]. C-peptide assays are not standardized either, so thresholds depend on the method [12].
What if both insulin and glucose are low?
A low glucose with low insulin after fasting is uncommon and needs a clinician. Low blood sugar is evaluated only when symptoms, a measured low glucose and relief with sugar occur together, and insulin is then measured during an episode.
The Endocrine Society recommends evaluating low blood sugar only when Whipple's triad is documented: symptoms, a low measured glucose and resolution of symptoms when glucose is raised. When the body may be making too much insulin, it advises measuring glucose, insulin, C-peptide, proinsulin and beta-hydroxybutyrate during an episode, plus insulin antibodies [13].
In people with diabetes, insulin or insulin secretagogue treatment is the most common cause of low blood sugar [13]. A routine fasting insulin test is not the right tool for this question.
More about Fasting insulin
- Fasting insulin: the full guideFasting insulin is the level of insulin in your blood after at least 8 hours without food.
- Fasting insulin test: why it is done and how to prepareA fasting insulin test is a blood test taken after at least 8 hours without food.
- How to calculate HOMA-IR from fasting insulin and glucoseHOMA-IR equals fasting glucose in mg/dL times fasting insulin in µIU/mL, divided by 405.
- What is a good fasting insulin level?Lab normal ranges for fasting insulin are wide, such as 2.6 to 24.9 µIU/mL (16 to 149 pmol/L).
- How to lower fasting insulinWeight loss lowers fasting insulin the most: in one trial it fell about 15% at 5% weight loss and about 48% at 16%.
Protocols that act on Fasting insulin
- Low-glycemic dietA low-glycemic diet favors carbohydrate foods that raise blood sugar slowly, rated by the glycemic index (GI): 55 or less is low and 70 or more is high.
- Time-restricted eatingTime-restricted eating means eating all of the day's food and caloric drinks within a consistent daily window, usually 6 to 10 hours, and fasting the rest of the day.
- Ketogenic dietA ketogenic diet keeps carbohydrate under about 20 to 50 g a day so the body burns fat and makes ketones, defined in supervised programs as blood BHB of 0.5 to 3.0 mmol/L.
- Zone 2 cardioZone 2 cardio is steady aerobic exercise held just below the first lactate threshold, where blood lactate stays near 2 mmol/L and you can still talk in full sentences.
Common questions
What causes low fasting insulin levels?
What are the symptoms of low fasting insulin?
Low insulin with normal glucose causes no symptoms. With high glucose, the ADA lists frequent urination, excessive thirst and unexplained weight loss [1].
Is a fasting insulin of 2 normal?
It is just below one common lab range of 2.6 to 24.9 µIU/mL [9]. With normal glucose it usually reflects good sensitivity; with high glucose it needs medical review.
Does a ketogenic diet lower fasting insulin?
Yes. Ketogenic diets lowered insulin 3.15 µU/mL more than Mediterranean diets in head-to-head trials [8].
Sources
- 1.American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026. Diabetes Care, 2026. doi:10.2337/dc26-S002
- 2.Buzzetti R, Tuomi T, Mauricio D, et al. Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel. Diabetes, 2020. doi:10.2337/dbi20-0017
- 3.Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabetic Medicine, 2013. doi:10.1111/dme.12159
- 4.Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes, 1988. doi:10.2337/diab.37.12.1595
- 5.Johnson JL, Duick DS, Chui MA, Aldasouqi SA. Identifying prediabetes using fasting insulin levels. Endocrine Practice, 2010. doi:10.4158/EP09031.OR
- 6.Jiao B, Li L, Hao Y, Wu S, Jiang S. Exercise and Insulin-Resistance Biomarkers in Adults With Overweight/Obesity: A Network Meta-Analysis of Randomised Controlled Trials. Diabetes, Obesity and Metabolism, 2026. doi:10.1111/dom.71340
- 7.Chatzi CA, Basios A, Markozannes G, et al. Effect of Different Dietary Patterns on Cardiometabolic Risk Factors: An Umbrella Review of Systematic Reviews and Meta-Analyses. Nutrients, 2024. doi:10.3390/nu16223873
- 8.Kun X, Roostaee A, Safarpour Lima Z, Rohani P. Comparative effects of ketogenic diets and mediterranean diets on obesity and metabolic outcomes: a systematic review and meta-analysis. Reviews in Endocrine and Metabolic Disorders, 2026. doi:10.1007/s11154-026-10086-x
- 9.Labcorp. Insulin (test 004333). Labcorp test menu, 2026. Link
- 10.Marcovina S, Bowsher RR, Miller WG, et al. Standardization of insulin immunoassays: report of the American Diabetes Association Workgroup. Clinical Chemistry, 2007. doi:10.1373/clinchem.2006.082214
- 11.Kawamoto R, Kikuchi A, Ninomiya D, Kumagi T, Abe M. Excessively Low Insulin Resistance May Increase the Risk of All-Cause Mortality Among Community-Dwelling Individuals Without Diabetes. Cureus, 2025. doi:10.7759/cureus.81773
- 12.Schleicher E, Kabytaev K, Nauck M, et al. Call for Standardization of C-Peptide Measurement. Journal of Diabetes Science and Technology, 2025. doi:10.1177/19322968251362848
- 13.Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism, 2009. doi:10.1210/jc.2008-1410